Susquehanna International Group
FULC icon

Susquehanna International Group’s Fulcrum Therapeutics FULC Stock Holding History

Susquehanna International Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$777K Buy
101,336
+13,406
+15% +$124K ﹤0.01% 8543
2025
Q4 		$994K Buy
87,930
+34,359
+64% +$350K ﹤0.01% 7207
2025
Q3 		$493K Sell
53,571
-45,919
-46% -$332K ﹤0.01% 8986
2025
Q2 		$684K Buy
99,490
+34,650
+53% +$185K ﹤0.01% 8421
2025
Q1 		$187K Buy
64,840
+24,063
+59% +$88.4K ﹤0.01% 11007
2024
Q4 		$192K Buy
40,777
+4,206
+12% +$15.5K ﹤0.01% 10775
2024
Q3 		$131K Sell
36,571
-45,024
-55% -$334K ﹤0.01% 10863
2024
Q2 		$506K Sell
81,595
-479,397
-85% -$3.63M ﹤0.01% 8240
2024
Q1 		$5.3M Sell
560,992
-105,601
-16% -$943K ﹤0.01% 3550
2023
Q4 		$4.5M Buy
666,593
+161,252
+32% +$715K ﹤0.01% 3879
2023
Q3 		$2.24M Buy
505,341
+258,113
+104% +$1.13M ﹤0.01% 4901
2023
Q2 		$816K Buy
247,228
+188,161
+319% +$553K ﹤0.01% 7148
2023
Q1 		$168K Buy
+59,067
New +$529K ﹤0.01% 10802
2022
Q4 		– Sell
-10,006
Closed -$65.3K – 12829
2022
Q3 		$81K Sell
10,006
-7,681
-43% -$55K ﹤0.01% 11868
2022
Q2 		$87K Buy
+17,687
New +$173K ﹤0.01% 11592
2021
Q2 		– Sell
-31,594
Closed -$372K – 12776
2021
Q1 		$372K Buy
+31,594
New +$391K ﹤0.01% 10143
2019
Q4 		– Sell
-13,397
Closed -$89K – 10001
2019
Q3 		$89K Buy
+13,397
New +$148K ﹤0.01% 9605

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Susquehanna International Group's FULC Position: Q1 2026 in Review

Susquehanna International Group increased its Fulcrum Therapeutics (FULC) stake by 15% in Q1 2026, buying an estimated $124K and bringing the position to 101,336 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #8543.

Susquehanna International Group first reported a position in FULC in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.3M in Q1 2024. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Susquehanna International Group held 101,336 shares of Fulcrum Therapeutics worth $777K as of Q1 2026.
  • Susquehanna International Group bought 13,406 Fulcrum Therapeutics shares in Q1 2026, an estimated $124K.
  • Fulcrum Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8543 holding.
  • Susquehanna International Group first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • Susquehanna International Group's Fulcrum Therapeutics position peaked at $5.3M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.